Technology | Orthopedic Imaging | June 13, 2018

EOS Imaging Announces FDA Clearance for hipEOS 3.0 Software

Next-generation surgical planning software simulates patient’s hip range of motion prior to total hip arthroplasty

June 13, 2018 – EOS imaging announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its hipEOS 3.0 surgical planning software.

hipEOS 3.0 is the latest generation of the surgical planning software for total hip arthroplasty (THA) and is part of the EOSapps suite of online 3-D surgical planning solutions (spineEOS, hipEOS, kneeEOS). The EOSapps — based on unbiased, weight-bearing EOS images and an accurate 2-D/3-D patient-specific data set — automatically select and best-position implants in 3-D. This enables surgeons to identify patient risks and develop customized plans based on each patient’s unique 3-D anatomy. Specifically, hipEOS 3.0 simulates the patient’s hip range of motion based on EOS functional standing and seated exams, allowing physicians to visualize and anticipate impingement and dislocation risks based on the position of the implant components.

When the hipEOS solution is utilized, the software offers an initial plan for the size and position of the implant components based on the patient’s 3-D data and anatomical model. The plan can be further adjusted by the physician with immediate feedback on how changes affect relevant clinical parameters. With the patient-specific data from full body, weight-bearing 2-D/3-D EOS images, hipEOS can be used to anticipate and better plan for the outcome of the surgical strategy, including leg length discrepancies, femoral offset and torsion, as well as hip mobility.

For more information: www.eos-imaging.com

Related Content

Siemens Partnership will make better health easier throughout Pennsylvania and in all communities that Geisinger serves

Getty Images

News | Radiology Business | June 08, 2020
June 8, 2020 — Siemens Healthineers and Geisinger have estab
Figure 4 for the study. Images of a 65-year-old man (patient 6). (a) Cardiac MRI perfusion shows perfusion deficit of anterior/anterolateral wall attributed to left anterior descending artery/left circumflex artery (*). (b) CT coronary angiography. (c) Coronary angiography, left anterior oblique projection with caudal angulation. (d) Three-dimensional image fusion helped refine diagnosis: perfusion deficits (*) were most likely caused by narrow first diagonal branch and its first, stented side branch.

Figure 4 for the study. Images of a 65-year-old man (patient 6). (a) Cardiac MRI perfusion shows perfusion deficit of anterior/anterolateral wall attributed to left anterior descending artery/left circumflex artery (*). (b) CT coronary angiography. (c) Coronary angiography, left anterior oblique projection with caudal angulation. (d) Three-dimensional image fusion helped refine diagnosis: perfusion deficits (*) were most likely caused by narrow first diagonal branch and its first, stented side branch (arrowhead). Retrospectively, denoted lesion could also be found at CT coronary angiography and coronary angiography (arrowheads in b and c, respectively). CT FFR = CT-derived fractional flow reserve, LGE = late gadolinium enhancement. Image courtesy of RSNA, Radiology.

News | Cardiac Imaging | May 04, 2020
May 4, 2020 – A new technique that combines computed tomography (CT) and magnetic resonance imaging MRI can bolster c
Konica Minolta Healthcare's Rede Mini PACS are designed for specialty practices such as orthopedic, urgent care and family medicine clinics
News | PACS | April 28, 2020
April 28, 2020 – Konica Minolta Healthcare Americas released its Rede...
Two examples of CT myocardial perfusion (CTP) imaging assessment software. Canon is on the left and GE Healthcare is on the right. Both of these technologies have been around for a few years, but there have been an increasing amount of clinical data from studies showing the accuracy of the technology compared to nuclear imaging, the current stand of care for myocardial perfusion imaging, and cardiac MRI. #SCCT #perfusionimaging 

Two examples of CT myocardial perfusion (CTP) imaging assessment software. Canon is on the left and GE Healthcare is on the right. Both of these technologies have been around for a few years, but there have been an increasing amount of clinical data from studies showing the accuracy of the technology compared to nuclear imaging, the current stand of care for myocardial perfusion imaging, and cardiac MRI.

News | Computed Tomography (CT) | March 16, 2020
March 16, 2020 — The Society of Cardiovascular Computed Tomography (SCCT) released a new...
Carestream’s X-ray digital tomosynthesis functionality creates three-dimensional datasets from digital radiography (DR) that can be scrolled through similar to computed tomography (CT) imaging. It received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in January 2020. Digital tomosynthesis uses a single sweep of X-ray exposures and streamlines operator workflow by separating the process of DT exposure acquisition from image volume formation.
News | Digital Radiography (DR) | January 15, 2020
January 15, 2020 — Carestream’s X-ray digital tomosynthesis (DT) functionality, which creates three-dimensional datas
Videos | Advanced Visualization | December 30, 2019
This is a hologram of a fracture from a...
Videos | RSNA | December 18, 2019
ITN Editor Dave Fornell and ITN Consulting Editor Greg Freiherr offer a post-game report on the trends and technologi